These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state. Wong AT; Chan DC; Barrett PH; Adams LA; Watts GF J Clin Endocrinol Metab; 2014 Aug; 99(8):E1427-35. PubMed ID: 24606094 [TBL] [Abstract][Full Text] [Related]
4. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men. Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237 [TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386 [TBL] [Abstract][Full Text] [Related]
7. Fat compartments and apolipoprotein B-100 kinetics in overweight-obese men. Watts GF; Chan DC; Barrett PH; Susekov AV; Hua J; Song S Obes Res; 2003 Jan; 11(1):152-9. PubMed ID: 12529498 [TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity. Chan DC; Watts GF; Gan S; Wong AT; Ooi EM; Barrett PH Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1043-50. PubMed ID: 20150556 [TBL] [Abstract][Full Text] [Related]
9. Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study. Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Robin I; Taskinen MR J Clin Endocrinol Metab; 2014 Nov; 99(11):4281-90. PubMed ID: 25077901 [TBL] [Abstract][Full Text] [Related]
10. Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity. Chan DC; Nguyen MN; Watts GF; Ooi EM; Barrett PH Am J Clin Nutr; 2010 Apr; 91(4):900-6. PubMed ID: 20181806 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men. Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083 [TBL] [Abstract][Full Text] [Related]
12. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
13. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338 [TBL] [Abstract][Full Text] [Related]
14. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. Riches FM; Watts GF; Hua J; Stewart GR; Naoumova RP; Barrett PH J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men. Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790 [TBL] [Abstract][Full Text] [Related]
16. Effects of moderate exercise on VLDL₁ and Intralipid kinetics in overweight/obese middle-aged men. Al-Shayji IA; Caslake MJ; Gill JM Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E349-55. PubMed ID: 22094472 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes. Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646 [TBL] [Abstract][Full Text] [Related]
18. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090 [TBL] [Abstract][Full Text] [Related]
19. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894 [TBL] [Abstract][Full Text] [Related]
20. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss. Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]